IPSEN BIOPHARMACEUTICALS INC

Ipsen Biopharmaceuticals Inc. specializes in the manufacturing of pharmaceutical preparations, with a focus on delivering specialized drug products and hematological therapeutics to federal healthcare systems. Their technical expertise lies in GMP-compliant production processes, drug formulation, and the supply chain management of complex biopharmaceuticals, including those used in oncology and rare disease treatment. The company demonstrates deep competency in meeting stringent regulatory standards for sterile and non-sterile drug manufacturing, ensuring consistent quality and traceability across batch production. Their ability to support long-term government supply agreements suggests strong operational scalability and adherence to FDA and VA-specific pharmaceutical compliance frameworks. The contractor maintains a consistent relationship with the Department of Veterans Affairs, providing critical pharmaceuticals under both blanket purchase agreements and Federal Supply Schedule contracts. Their work supports VA’s mission to deliver reliable, uninterrupted access to specialty medications for veteran populations, particularly in areas such as hematology and chronic disease management. This recurring engagement reflects a trusted partnership built on regulatory reliability, consistent product availability, and alignment with VA’s formulary and distribution protocols. Ipsen operates primarily within NAICS 325412, which encompasses the manufacturing of finished pharmaceutical products from active pharmaceutical ingredients. Their market positioning centers on niche therapeutic areas requiring precise formulation and controlled distribution, positioning them as a qualified supplier for federal agencies managing complex drug regimens. They are not a broad-spectrum distributor but a specialized manufacturer focused on high-integrity, clinically essential medications. As a 2L entity headquartered in Cambridge, Massachusetts, Ipsen Biopharmaceuticals Inc. is structured as a mid-sized manufacturer with a focused government market presence. The company holds no formal government certifications but maintains operational compliance through rigorous internal quality systems aligned with federal pharmaceutical standards. Their geographic proximity to major biopharma hubs enhances their ability to collaborate with federal research and procurement networks.